“I had a feeling already that it wasn’t gonna be just my stomach,” Irene Sinsombutcharoen tells PEOPLE ...
The Chosun Ilbo on MSN
Carbon-iron injection shows 84.2% efficacy in early cancer trials
Chinese researchers are developing an injectable treatment combining tiny carbon particles and iron to inhibit cancer cell ...
A two-stage neural network fusion system from Romanian researchers achieved 93.53% F1 score in segmenting ovarian tumors from ...
Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases including recurrent and metastatic cancer, ...
A new study shows that the microRNA-197-3p molecule, which is depleted in ovarian cancer, directly suppresses the collagen ...
Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a pioneer in differentiated targeted radiotherapies with the potential to transform cancer treatment, today announced ...
Learn how Anixa is advancing two clinical-stage oncology programs through differentiated immunotherapy and vaccine ...
Compugen (NASDAQ:CGEN) outlined the clinical rationale for its COM701 antibody in platinum-sensitive ovarian cancer and ...
Colorectal cancer has become the leading cause of cancer-related death for people under 50. Its most common forms generally ...
At 92, Miriam Feder has found yet another purpose in life. The Brooklyn-born Eldorado resident has devoted herself to plenty ...
In a phase 1 trial of patients with platinum-sensitive high-grade ovarian cancer, a personalized neoantigen vaccine plus ...
The investigational drug rinatabart sesutecan (Rina-S) shrank tumors in 45.9% of patients with platinum-resistant ovarian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results